Changeflow GovPing Drug Safety PMDA Japan Drug Precaution Revisions
Favicon for www.pmda.go.jp

PMDA Japan Drug Precaution Revisions

RSS
1d ago • PMDA Japan Drug Precaution Revisions
Favicon for www.pmda.go.jp

Japan PMDA Drug Precaution Revisions for FY2025

The Japan Pharmaceuticals and Medical Devices Agency (PMDA) has published a list of drug precaution revisions for Fiscal Year 2025, detailing updates for various nonproprietary drug names. These revisions are effective on specific dates in late 2025 and early 2026, with associated investigation summaries available.

Priority review Guidance Pharmaceuticals
1d ago • PMDA Japan Drug Precaution Revisions
Favicon for www.pmda.go.jp

PMDA Japan Drug Precaution Revisions

The PMDA Japan has updated drug precautions for several medications, including Andexanet alfa, Topiramate, and various VEGF/VEGFR inhibitors. These revisions reflect new safety information and investigation results, impacting the labeling and handling of these drugs.

Priority review Guidance Pharmaceuticals

Source details

Category
Drug Safety
Country
JP

Activity

Changes tracked
2
Changes in last month
2
Last change detected
1d ago

Browse Categories

Federal Courts 26 State Courts 91 Securities Regulation 6 Financial Regulation 43 Consumer Protection 5 Drug Safety 45 Data Protection 21 Competition 2 Attorneys General 3 Insurance Regulation 5 Trade & Export 36 Legislation 42 Energy Regulation 13 Environment 3 Labor & Employment 2 Tax 1

Get Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get PMDA Japan Drug Precaution Revisions alerts

We'll email you when PMDA Japan Drug Precaution Revisions publishes new changes.

Free. Unsubscribe anytime.